More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit.

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

Un estudio observacional con más de 110 000 mujeres abre la puerta a utilizar estos populares medicamentos para la pérdida de peso como prevención oncológica.

About 42,140 women are expected to die from breast cancer in the U.S. this year

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity…

Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.

More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm…

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.

Use of drugs for overweight/obesity linked to lower risk of breast cancer, several leukemias

The potential benefits of GLP-1 drugs, like Ozempic or Wegovy, are stacking up.